Historical salary details - Mr. Howard W. Robin, Director, President and Chief Executive Officer, Nektar Therapeutics
Mr. Howard W. Robin has been the Director, President and Chief Executive Officer of Nektar Therapeutics since 29 Apr 2007 and his latest salary was 3.8 M. View his historical salary.
Mr. Howard W. Robin
Director, President and Chief Executive Officer
$ 3.8 M
Gross Remuneration
-
Current Company
Nektar Therapeutics
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Nektar Therapeutics | Director, President and Chief Executive Officer | 3.8 M | - |
| 2022 | Nektar Therapeutics | Director, President and Chief Executive Officer | - | - |
| 2021 | Nektar Therapeutics | Director, President and Chief Executive Officer | 11.2 M | -0.8 % |
| 2020 | Nektar Therapeutics | Director, President and Chief Executive Officer | 11.2 M | 13.1 % |
| 2020 | Nektar Therapeutics | - | 11.2 M | 13.1 % |
| 2019 | Nektar Therapeutics | - | 9.9 M | -14.9 % |
| 2019 | Nektar Therapeutics | Director, President and Chief Executive Officer | 9.9 M | -14.9 % |
| 2019 | Nektar Therapeutics | - | 9.9 M | -14.9 % |
| 2018 | Nektar Therapeutics | - | 13.3 M | -19.2 % |
| 2018 | Nektar Therapeutics | - | 13.3 M | -19.2 % |
| 2018 | Nektar Therapeutics | Director, President and Chief Executive Officer | 11.7 M | -29.2 % |
| 2017 | Nektar Therapeutics | Director, President and Chief Executive Officer | 18.1 M | 368.0 % |
| 2017 | Nektar Therapeutics | - | 18.1 M | 368.0 % |
| 2017 | Nektar Therapeutics | - | 16.5 M | 326.6 % |
| 2016 | Nektar Therapeutics | - | 4.8 M | 7.2 % |
| 2016 | Nektar Therapeutics | Director, President and Chief Executive Officer | 4.8 M | 7.2 % |
| 2016 | Nektar Therapeutics | - | 3.9 M | -13.0 % |
| 2015 | Nektar Therapeutics | - | 4.4 M | -44.7 % |
| 2015 | Nektar Therapeutics | Director, President and Chief Executive Officer | 4.4 M | -44.7 % |
| 2015 | Nektar Therapeutics | - | 4.4 M | -44.7 % |
| 2014 | Nektar Therapeutics | Director, President and Chief Executive Officer | 8.0 M | 125.0 % |
| 2014 | Nektar Therapeutics | - | 8.0 M | 125.0 % |
| 2014 | Nektar Therapeutics | - | 8.0 M | 125.0 % |
| 2013 | Nektar Therapeutics | - | 3.6 M | 10.1 % |
| 2013 | Nektar Therapeutics | - | 3.6 M | 10.1 % |
| 2013 | Nektar Therapeutics | Director, President and Chief Executive Officer | 3.6 M | 10.1 % |
| 2012 | Nektar Therapeutics | Director, President and Chief Executive Officer | 3.2 M | 2.1 % |
| 2012 | Nektar Therapeutics | - | 3.2 M | 2.0 % |
| 2012 | Nektar Therapeutics | - | 3.2 M | 2.0 % |
| 2011 | Nektar Therapeutics | - | 3.2 M | -29.2 % |
| 2011 | Nektar Therapeutics | Director, President and Chief Executive Officer | 3.2 M | -29.2 % |
| 2011 | Nektar Therapeutics | - | 3.2 M | -29.3 % |
| 2010 | Nektar Therapeutics | - | 4.5 M | 49.6 % |
| 2010 | Nektar Therapeutics | - | 4.5 M | 49.6 % |
| 2010 | Nektar Therapeutics | Director, President and Chief Executive Officer | 4.5 M | 49.6 % |
| 2009 | Nektar Therapeutics | - | 3.0 M | 39.7 % |
| 2009 | Nektar Therapeutics | - | 3.0 M | 39.7 % |
| 2009 | Nektar Therapeutics | Director, President and Chief Executive Officer | 3.0 M | 39.7 % |
| 2008 | Nektar Therapeutics | - | 2.5 M | 12.5 % |
| 2008 | Nektar Therapeutics | - | 2.5 M | 12.5 % |
| 2008 | Nektar Therapeutics | Director, President and Chief Executive Officer | 2.1 M | -3.5 % |
| 2007 | Nektar Therapeutics | - | 8.6 M | - |
| 2007 | Nektar Therapeutics | - | 2.2 M | - |
| 2007 | Nektar Therapeutics | Director, President and Chief Executive Officer | 2.2 M | - |